Asian Stocks Mixed on COVID Fears, New China Law By

Asian Stocks Mixed After Disappointing Chinese Inflation Data By

© Reuters.

By Adam Claringbull – Asian markets were mixed on Friday morning, with ever-rising COVID-19 cases the main driver. China is also to bring in new national security export laws, causing investor uncertainty.

China is to promulgate a new national security law controlling what it deems to be sensitive exports. The new law is likely to take a similar form to that of the U.S. Department of Commerce’s Entity List, whereby certain companies and entities are prohibited from receiving certain technologies and strategic materials.

The exact mechanics of this law are yet to be public, and investors are uncertain as to quite how it will affect international trade. Companies are wary about how they will deal with the competing national interests of China and the U.S.

China’s was up 0.31% at 11:09 PM ET (3:09 AM GMT) and the fell 0.47%.

In Australia, the S was down 0.32% and in South Korea, the fell 0.58%, after a quick opening fall and rally.

Hong Kong’s gained 0.72%.

Japan’s returned to parity after an early fall, inching up 0.03%.

The U.S. COVID-19 stimulus response once again produced uncertainty in markets, with yet another offer from U.S. President Donald Trump. However, few investors are expecting a deal to passed before the Nov. 3 elections. The new deal is larger than previous offers, giving some investors confidence in the size of the final package.

A rise in also gave cause for concern about economic recovery. 898,000 Americans claimed unemployment over the past week, higher than the 825,000 claims forecast and hitting a two-month high.

“The market’s on again off again love affair with an impending stimulus torrent masks the fact that investor uncertainty is bristling ahead of an expected choppy period in terms of headline risk, including Brexit, the U.S. election, and perhaps the most horrifying troubles of all, the second wave of the coronavirus that could trigger more intense lockdown worries,” Stephen Innes, global chief market strategist at AxiCorp, told Reuters.

COVID-19 continues to ravage the global economy, with no end in sight as global case numbers continue to rise, and a second wave strikes Europe and the U.S. Global cases have now reached 38.8 million, with deaths passing the 1.1 million mark, according to Johns Hopkins University data.

“There’s a bit of worry there and also at what we’re seeing in America and in Europe regarding the virus and how it seems to be taking hold pretty significantly again,” Grant Williamson, investment adviser at Hamilton Hindin Greene, told Reuters.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

About us

InvestLab is a financial services technology company focused on the global trading market. Founded in 2010 in Hong Kong, the company develops trading, market data, and social research products that enable individual investors and small to mid-size brokers to access global markets. We provide brokers and financial institutions cross border capabilities for retail investors into 43 markets globally.